CD4 and non-small cell lung carcinoma: showed that two CAF subsets drive primary resistance to ICIs in mature TLS (mTLS)‐positive NSCLC by promoting immune exclusion, CD8+ T cell exhaustion, and regulatory CD4+ T cell infiltration, highlighting their immunosuppressive roles and potential as therapeutic targets.[265]